Optimizing androgen deprivation therapy (ADT) in advanced prostate cancer
touchEXPERT OPINIONS for touchONCOLOGY
An oncologist, a nurse and a urologist share their insights on the risks and benefits of androgen deprivation therapy, the barriers to equitable care and how to improve treatment adherence for patients with prostate cancer.
The experts
Dr Tanya Dorff, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
Ms Brenda Martone, Northwestern Medicine, Chicago, IL, USA
Dr Stephen Freedland, Cedars-Sinai, Los Angeles, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Pfizer Inc. and is jointly…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.